Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
European Journal of Vascular Surgery|February 1, 1990
Reversal of depressed oxygen consumption accompanying in vivo protamine sulphate-heparin interactions by the prostacyclin analogue, iloprostT W Wakefield, S K Wrobleski, J C StanleyJournal of Thrombosis and Haemostasis : JTH|February 17, 2015
Inferior vena cava branch variations in C57BL/6 mice have an impact on thrombus size in an IVC ligation (stasis) modelJ A Diaz, D M Farris, S K Wrobleski, et al.Journal of Vascular Surgery|July 1, 1992
Heparin-mediated reductions of the toxic effects of protamine sulfate on rabbit myocardiumT W Wakefield, S K Wrobleski, B J Nichol, et al.Surgery|February 1, 1996
Effects of differing rates of protamine reversal of heparin anticoagulationT W Wakefield, C B Hantler, S K Wrobleski, et al.The Journal of Surgical Research|May 1, 1991
Increased prostacyclin and adverse hemodynamic responses to protamine sulfate in an experimental canine modelT W Wakefield, S K Wrobleski, D J Wirthlin, et al.ASAIO Journal (American Society for Artificial Internal Organs : 1992)|July 1, 1993
Tissue distribution, circulating half-life, and excretion of intravenously administered protamine sulfateA DeLucia, T W Wakefield, A M Kadell, et al.Journal of Investigative Surgery : the Official Journal of the Academy of Surgical Research|July 27, 1999
Detection of perivenous inflammation in a rat model of venous thrombosis using MRVF J Londy, A M Kadell, S K Wrobleski, et al.Annals of Surgery|October 1, 1990
Impaired myocardial function and oxygen utilization due to protamine sulfate in an isolated rabbit heart preparationT W Wakefield, L E Bies, S K Wrobleski, et al.Journal of Vascular Surgery|May 1, 1995
Effective and less toxic reversal of low-molecular weight heparin anticoagulation by a designer variant of protamineT W Wakefield, P C Andrews, S K Wrobleski, et al.The Journal of Surgical Research|June 1, 1996
A [+18RGD] protamine variant for nontoxic and effective reversal of conventional heparin and low-molecular-weight heparin anticoagulationT W Wakefield, P C Andrews, S K Wrobleski, et al.Pageof 3